Advisor Group Holdings, Inc. 4 D Molecular Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$15.16 - $23.26 $3,198 - $4,907	-211 Reduced 11.81%	1,575 $28,000
Q1 2023 May 12, 2023	BUY	$15.45 - $23.19 $1,344 - $2,017	87 Added 5.12%	1,786 $30,000
Q4 2022 Feb 10, 2023	SELL	$6.85 - $25.46 $27,537 - $102,349	-4,020 Reduced 70.29%	1,699 $37,000
Q1 2022 May 04, 2022	SELL	$13.16 - $22.64 $2,052 - $3,531	-156 Reduced 2.66%	5,719 $86,000
Q2 2021 Aug 02, 2021	BUY	$22.2 - $42.29 $130,425 - $248,453	5,875 New	5,875 $141,000

157

50.3M

718K

370K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $675M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.